Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

AUGX

Augmedix (AUGX)

Augmedix Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:AUGX
DateTimeSourceHeadlineSymbolCompany
14/05/202406:15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:AUGXAugmedix Inc
14/05/202406:09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AUGXAugmedix Inc
14/05/202406:03GlobeNewswire Inc.Augmedix Delivers 40% Revenue Growth for First Quarter of 2024NASDAQ:AUGXAugmedix Inc
03/05/202421:00GlobeNewswire Inc.Augmedix to Participate in Upcoming Investor Conferences in May and June 2024NASDAQ:AUGXAugmedix Inc
30/04/202421:00GlobeNewswire Inc.Augmedix to Announce First Quarter 2024 Financial Results on May 13, 2024NASDAQ:AUGXAugmedix Inc
26/04/202406:05GlobeNewswire Inc.Augmedix Awarded on Newsweek’s World’s Best Digital Health Companies 2024 ListNASDAQ:AUGXAugmedix Inc
24/04/202421:00GlobeNewswire Inc.Augmedix Launches Industry’s First Fully-Automated, GenAI-Powered, Medical Documentation Product for Emergency DepartmentsNASDAQ:AUGXAugmedix Inc
09/04/202421:00GlobeNewswire Inc.Augmedix Integrates with Andor Health to Revolutionize Ambient Clinical Documentation for Ambulatory Virtual CareNASDAQ:AUGXAugmedix Inc
04/04/202422:00GlobeNewswire Inc.Augmedix and SADA Forge Partnership to Scale Ambient Documentation and Structured Data Products to Health Systems NationwideNASDAQ:AUGXAugmedix Inc
19/03/202422:33IH Market NewsUnilever Initiates Ice Cream Division Spin-Off and Announces Job Cuts; Berkshire Ramps Up Share Buyback Efforts, and MoreNASDAQ:AUGXAugmedix Inc
19/03/202407:01GlobeNewswire Inc.Augmedix Delivers 45% Revenue Growth and Expanded Gross Margins for Fourth Quarter of 2023NASDAQ:AUGXAugmedix Inc
12/03/202422:00GlobeNewswire Inc.Augmedix Announces New Positive Data and Enhancements to Its Ambient AI Product, Augmedix GoNASDAQ:AUGXAugmedix Inc
08/03/202423:00GlobeNewswire Inc.Augmedix to Announce Fourth Quarter and Full Year 2023 Financial Results on March 18, 2024NASDAQ:AUGXAugmedix Inc
05/03/202412:54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AUGXAugmedix Inc
28/02/202412:33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AUGXAugmedix Inc
28/02/202412:32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AUGXAugmedix Inc
28/02/202412:32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AUGXAugmedix Inc
28/02/202412:31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AUGXAugmedix Inc
28/02/202412:31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AUGXAugmedix Inc
28/02/202412:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AUGXAugmedix Inc
27/02/202423:00GlobeNewswire Inc.Augmedix to Participate in Citizens JMP Technology ConferenceNASDAQ:AUGXAugmedix Inc
13/02/202423:00GlobeNewswire Inc.Augmedix Names Tomer Levy as New Senior Vice President of EngineeringNASDAQ:AUGXAugmedix Inc
10/02/202406:14Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:AUGXAugmedix Inc
23/01/202408:15GlobeNewswire Inc.Maxim Group LLC to Host the 2024 Healthcare IT Virtual Conference on Wednesday, January 24th & Thursday, January 25th at 9:00 A.M. ETNASDAQ:AUGXAugmedix Inc
16/01/202423:00GlobeNewswire Inc.Augmedix Announces Participation in Maxim Group Virtual Healthcare IT Investor ConferenceNASDAQ:AUGXAugmedix Inc
10/01/202408:14Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:AUGXAugmedix Inc
10/01/202408:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AUGXAugmedix Inc
06/01/202408:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AUGXAugmedix Inc
06/01/202400:00GlobeNewswire Inc.Augmedix Exits Calendar 2023 with Expected $51 Million in Annual Recurring RevenueNASDAQ:AUGXAugmedix Inc
20/12/202313:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AUGXAugmedix Inc
 Showing the most relevant articles for your search:NASDAQ:AUGX